Clinical Trials Browser

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT07288931 2025-12-17

Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

Phase NA Recruiting

40 enrolled

CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT06377033 2025-07-20

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Phase NA Recruiting

1,000 enrolled

CNSEndocrine

Alzheimer Disease, Paraganglioma, Parkinson Disease, Pheochromocytoma, Polyneuropathies, Aortic Aneurysm, Thoracic, Genetic Predisposition to Disease, Frontotemporal Dementia

NCT04605848 2024-05-09

MICROBAT

Phase NA Terminated

7 enrolled

CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT02186678 2023-04-06

DOTATATE

Phase NA Completed

30 enrolled

CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT03344016 2020-07-09

MUPPET

Phase NA Recruiting

1,148 enrolled

CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT01347307 2020-06-18

Stereotactic Body Radiotherapy for Spine Tumors

Phase NA Completed

38 enrolled 11 charts

CNSEndocrineSarcoma

Arteriovenous Malformations, Chordoma, Meningioma, Neurilemmoma, Neurofibroma, Paraganglioma

NCT02672020 2019-09-24

COMETETACTIC

Phase NA Completed

448 enrolled

CNSEndocrine

Adrenal Gland Neoplasms, Paraganglioma, Pheochromocytoma, Adrenocortical Carcinoma

Clinical Trials

PHEO

Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

MICROBAT

DOTATATE

MUPPET

Stereotactic Body Radiotherapy for Spine Tumors

COMETETACTIC